HomeNerviano Medical Sciences to present a novel orally available selective small molecule Cdc7 inhibitor at the AACR Annual Meeting 2014

Nerviano Medical Sciences to present a novel orally available selective small molecule Cdc7 inhibitor at the AACR Annual Meeting 2014

Nerviano, 25.02.2014

Nerviano Medical Sciences will disclose data on a novel orally available selective small molecule Cdc7 inhibitor at the AACR Annual Meeting 2014.

NMS-P862, a novel orally available selective small molecule Cdc7 inhibitor with antitumor efficacy in breast cancer. Montagnoli, A et al.

Abstract number: 4539/25. Presentation time: Tue, Apr 08, 1:00 - 5:00 PM

Further details will be disclosed when abstract bodies will be made available on the conference website, at the following link.